Literature DB >> 15557662

The calcineurin target, Crz1, functions in azole tolerance but is not required for virulence of Candida albicans.

Chiatogu Onyewu1, Floyd L Wormley, John R Perfect, Joseph Heitman.   

Abstract

In Candida albicans, calcineurin is essential for virulence and survival during membrane perturbation by azoles. Crz1 is a proposed downstream target of calcineurin based on studies of Saccharomyces cerevisiae. However, the in vitro phenotypes of C. albicans crz1/crz1 and calcineurin mutants differ and Crz1 is not required for virulence.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15557662      PMCID: PMC529171          DOI: 10.1128/IAI.72.12.7330-7333.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Calcineurin is essential for survival during membrane stress in Candida albicans.

Authors:  M Cristina Cruz; Alan L Goldstein; Jill R Blankenship; Maurizio Del Poeta; Dana Davis; Maria E Cardenas; John R Perfect; John H McCusker; Joseph Heitman
Journal:  EMBO J       Date:  2002-02-15       Impact factor: 11.598

2.  Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans.

Authors:  O Marchetti; P Moreillon; M P Glauser; J Bille; D Sanglard
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

3.  A single-transformation gene function test in diploid Candida albicans.

Authors:  B Enloe; A Diamond; A P Mitchell
Journal:  J Bacteriol       Date:  2000-10       Impact factor: 3.490

4.  Fluconazole plus cyclosporine: a fungicidal combination effective against experimental endocarditis due to Candida albicans.

Authors:  O Marchetti; J M Entenza; D Sanglard; J Bille; M P Glauser; P Moreillon
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

5.  Calcineurin-dependent regulation of Crz1p nuclear export requires Msn5p and a conserved calcineurin docking site.

Authors:  Leila M Boustany; Martha S Cyert
Journal:  Genes Dev       Date:  2002-03-01       Impact factor: 11.361

6.  An improved transformation protocol for the human fungal pathogen Candida albicans.

Authors:  Andrea Walther; Jürgen Wendland
Journal:  Curr Genet       Date:  2003-01-30       Impact factor: 3.886

7.  Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei.

Authors:  Chiatogu Onyewu; Jill R Blankenship; Maurizio Del Poeta; Joseph Heitman
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

8.  Comparison of caspofungin and amphotericin B for invasive candidiasis.

Authors:  Jorge Mora-Duarte; Robert Betts; Coleman Rotstein; Arnaldo Lopes Colombo; Luis Thompson-Moya; Juanita Smietana; Robert Lupinacci; Carole Sable; Nicholas Kartsonis; John Perfect
Journal:  N Engl J Med       Date:  2002-12-19       Impact factor: 91.245

9.  Calcineurin A of Candida albicans: involvement in antifungal tolerance, cell morphogenesis and virulence.

Authors:  Dominique Sanglard; Françoise Ischer; Oscar Marchetti; José Entenza; Jacques Bille
Journal:  Mol Microbiol       Date:  2003-05       Impact factor: 3.501

10.  Calcineurin is essential for Candida albicans survival in serum and virulence.

Authors:  Jill R Blankenship; Floyd L Wormley; Molly K Boyce; Wiley A Schell; Scott G Filler; John R Perfect; Joseph Heitman
Journal:  Eukaryot Cell       Date:  2003-06
View more
  57 in total

1.  Calcineurin is required for Candida albicans to survive calcium stress in serum.

Authors:  Jill R Blankenship; Joseph Heitman
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Roles of calcineurin and Crz1 in antifungal susceptibility and virulence of Candida glabrata.

Authors:  Taiga Miyazaki; Shunsuke Yamauchi; Tatsuo Inamine; Yosuke Nagayoshi; Tomomi Saijo; Koichi Izumikawa; Masafumi Seki; Hiroshi Kakeya; Yoshihiro Yamamoto; Katsunori Yanagihara; Yoshitsugu Miyazaki; Shigeru Kohno
Journal:  Antimicrob Agents Chemother       Date:  2010-01-25       Impact factor: 5.191

Review 3.  Stress, drugs, and evolution: the role of cellular signaling in fungal drug resistance.

Authors:  Leah E Cowen; William J Steinbach
Journal:  Eukaryot Cell       Date:  2008-03-28

Review 4.  Direct effects of non-antifungal agents used in cancer chemotherapy and organ transplantation on the development and virulence of Candida and Aspergillus species.

Authors:  Sharon C-A Chen; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Virulence       Date:  2011-07-01       Impact factor: 5.882

5.  Calcineurin target CrzA regulates conidial germination, hyphal growth, and pathogenesis of Aspergillus fumigatus.

Authors:  Robert A Cramer; B Zachary Perfect; Nadthanan Pinchai; Steven Park; David S Perlin; Yohannes G Asfaw; Joseph Heitman; John R Perfect; William J Steinbach
Journal:  Eukaryot Cell       Date:  2008-05-02

Review 6.  Signaling cascades as drug targets in model and pathogenic fungi.

Authors:  Robert J Bastidas; Jennifer L Reedy; Helena Morales-Johansson; Joseph Heitman; Maria E Cardenas
Journal:  Curr Opin Investig Drugs       Date:  2008-08

7.  A phenotypic profile of the Candida albicans regulatory network.

Authors:  Oliver R Homann; Jeanselle Dea; Suzanne M Noble; Alexander D Johnson
Journal:  PLoS Genet       Date:  2009-12-24       Impact factor: 5.917

8.  Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin.

Authors:  Sheena D Singh; Nicole Robbins; Aimee K Zaas; Wiley A Schell; John R Perfect; Leah E Cowen
Journal:  PLoS Pathog       Date:  2009-07-31       Impact factor: 6.823

9.  Identification of possible targets of the Aspergillus fumigatus CRZ1 homologue, CrzA.

Authors:  Frederico M Soriani; Iran Malavazi; Marcela Savoldi; Eduardo Espeso; Taísa M Dinamarco; Luciano A S Bernardes; Márcia E S Ferreira; Maria Helena S Goldman; Gustavo H Goldman
Journal:  BMC Microbiol       Date:  2010-01-15       Impact factor: 3.605

10.  Hsp90 orchestrates stress response signaling governing fungal drug resistance.

Authors:  Leah E Cowen
Journal:  PLoS Pathog       Date:  2009-08-28       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.